Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response

about

Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response

Item

http://www.wikidata.org/entity/Q36360009

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@ast

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@en

type

Item

label

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@ast

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@en

prefLabel

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@ast

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@en

P1476

Imiquimod 5% as Adjuvant Thera ...... to Monitor Treatment Response

@en

P2093

Sonia Toussaint-Caire

http://www.w3.org/2001/XMLSchema#string

P2860

Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting

Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.

Dermoscopy of early recurrent basal cell carcinoma.

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.

Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring.

The dermatologist's stethoscope-traditional and new applications of dermoscopy.

An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma.

Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.

Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.

P2888

s13555-015-0088-z

P304

265-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13555-015-0088-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo Roldán-Marín

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283513989

http://www.w3.org/2001/XMLSchema#string

P698

26538104

http://www.w3.org/2001/XMLSchema#string

P932

4674454

http://www.w3.org/2001/XMLSchema#string